The technology allows the drape to be used without harming fragile or sensitive skin.
Surgical site infections (SSIs) are a costly and avoidable risk for health care workers and patients alike. To minimize the possibility of contamination, which can lead to SSI, Cardinal Health has developed a new and unique technology, the Cardinal Health CHG surgical incise drapes with BeneHold™ CHG adhesive technology. Tina Keller, senior consultant of clinical operations at Cardinal Health, discussed the new technology with Infection Control Today® (ICT®) after debuting it at the Association of periOperative Registered Nurses (AORN) Surgical Conference & Expo, held March 19-23 in New Orleans, Louisiana.
ICT®: Please tell us about this unique technology.
Keller: This is the first surgical incise drape with CHG [chlorhexidine gluconate], which supports clinicians in minimizing the risk of surgical site contamination. Cardinal Health CHG surgical incise drapes, with BeneHold™ CHG adhesive technology (from Avery Dennison), are safe for use on patients with fragile or sensitive skin because the drapes remove easily after the surgery is complete, including the ability to remove without harm to fragile skin. The drapes also meet ISO and FDA requirements for cytotoxicity, irritation, acute systemic toxicity, skin sensitization, and pyrogenicity.
ICT®: What are the features that makes technology so unique?
Keller: The strong, conformable, and breathable polyurethane incise film provides a sterile surface, and creates a barrier to contamination, isolating the skin from sterile gloves, gowns, instruments, and implants. The adhesive technology, BeneHold™ CHG, resulted in significantly reduced MRSA [methicillin-resistant Staphylococcus aureus] contamination around the incise area when compared to nonantimicrobial incise. Further, the drape’s breathable film encourages good adhesion and avoids moisture build-up underneath the drape.
ICT®: What sparked the creation of the incision drape?
Keller: Surgical site infections remain a significant issue for our customers, and their patients—SSIs occur in at least 2 to 4% of all patients. Plus, SSIs are associated with a mortality rate of 3%, with 75% of SSI-associated deaths directly attributed to the SSI. We wanted to identify a product improvement that would help reduce the risk of surgical site infections. Working with Avery Dennison—and their CHG adhesive technology—created an ideal opportunity for this product innovation.
ICT®: How does this product help infection preventionists specifically?
Keller: Our whitepaper shows that a novel CHG surgical incise drape was effective in significantly reducing MRSA contamination in an incisional wound model. This compilation and review of the published and unpublished data on the Cardinal Health™ Surgical Incise Drape with BeneHold™ CHG adhesive technology demonstrates its ability to reduce the harmful organisms in in-vitro and in-vivo animal studies. Studies of the drapes’ mechanical properties document reduced drape lift and the ability to adhere to the skin without damage on removal, including from fragile skin. Finally, a recent study clearly documented that this novel surgical incise drape impregnated with CHG was effective in significantly reducing MRSA contamination when compared with a nonantimicrobial drape or an iodophor impregnated drape.
ICT®: What has the reaction been to incision drape thus far?
Keller: Feedback from nurses at AORN has been very favorable. Most are excited to see the innovation in a product they use so frequently…it’s a simple, impactful way we can help keep patients safter and improve outcomes.
ICT®: Is there anything else that you’d like to add for our readers?
Keller: We’re really proud of this collaboration with Avery Dennison. I think some users might be curious about the performance of the drape with the CHG adhesive, and the drape really does hold up to the stresses of manipulation, retraction, and irrigation during surgery. Plus, adhesion is critical to ensure that the drape covers the incision throughout surgery without edge lift. Even with the CHG, the adhesion is extremely reliable.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.
Why Clinical Expertise Is the Cornerstone to Your Most Profitable Business Line
November 14th 2024Perioperative nurses bring vital skills in patient safety, infection control, and quality improvement. They enhance surgical outcomes and support health care systems during complex, high-risk procedures.